a-fib.com
Revised Article: Warfarin vs. Pradaxa and the Other New Anticoagulants (NOACs)
When the FDA approval the reversal agent, Andexxa, for the NOACs Xarelto and Eliquis, we totally revised our article on 'Warfarin and the new NOACs'.